10 results
6-K
IFRX
InflaRx N.V.
24 Feb 21
Current report (foreign)
4:16pm
, to applicable anti-kickback, fraud and abuse, false claims, physician payment transparency, health information privacy and security and other healthcare … for which we obtain marketing approval. In addition, we may be subject to transparency laws and patient privacy regulation by the federal government
20-F
2017 FY
IFRX
InflaRx N.V.
29 Mar 18
Annual report (foreign)
12:00am
claims, physician payment transparency, health information privacy and security and other healthcare laws and regulations, which could expose us … , we may be subject to transparency laws and patient privacy regulation by the federal government and by the U.S. states and foreign jurisdictions
20-F/A
2018 FY
IFRX
InflaRx N.V.
29 Mar 19
Annual report (foreign) (amended)
4:23pm
, to applicable anti-kickback, fraud and abuse, false claims, physician payment transparency, health information privacy and security and other … drugs for which we obtain marketing approval. In addition, we may be subject to transparency laws and patient privacy regulation by the federal
424B4
gkbv4ntg
7 May 18
Prospectus supplement with pricing info
4:47pm
F-1
m9o61
2 May 18
Registration statement (foreign)
7:10am
- Prev
- 1
- Next